Senior-clinician companion to introductory Pathology notes. Educational use only.
A Word From Your Senior
Pathology is a disciplined answer to three questions: what changed, why did it change, and what does that change predict? Never let a dramatic label erase the specimen, clinical context, or degree of certainty.
Injury, Adaptation, and Death
Cells may adapt through hypertrophy, hyperplasia, atrophy, or metaplasia. Injury can be reversible or progress to cell death. Necrosis commonly provokes inflammation; apoptosis is regulated cell death and is not invariably inflammatory. The boundary depends on mechanism, intensity, duration, and tissue reserve.
Inflammation and Repair
Acute and chronic inflammation describe dominant patterns, not simply duration. Inflammation can eliminate threats and initiate repair, but dysregulated inflammation damages tissue. Healing may restore tissue, regenerate it incompletely, or replace it with fibrosis. Infection, ischaemia, diabetes, nutrition, steroids, smoking, tension, and foreign material alter healing.
Thrombosis and Cancer
Thrombosis is promoted by endothelial injury, abnormal flow, and hypercoagulability, but patient risk is dynamic. Cancer reflects acquired biological capabilities, clonal evolution, host interaction, and selection pressure; it is not merely a cell "forgetting to stop." Grade, stage, biomarkers, margins, and molecular findings answer different questions.
Bedside Case
A pathology report says "atypical cells, suspicious but not diagnostic." Do not translate that to the patient as confirmed cancer. Clarify specimen adequacy, differential diagnosis, recommended ancillary tests or repeat sampling, radiological concordance, and multidisciplinary review. Preserve uncertainty accurately while accelerating the next step.
Accuracy Guardrails
- A biopsy samples tissue; sampling error and heterogeneity remain possible.
- "Benign" does not always mean harmless by location or hormone effect.
- "Malignant" does not define prognosis without type, stage, biology, and patient context.
- Autoimmune disease is not simply immunity attacking "by mistake"; loss of tolerance and tissue injury have diverse mechanisms.
- Biomarkers support a diagnosis or treatment choice only within validated context.
Ward-Round Questions
- Is the specimen representative and adequate?
- What is observed fact versus pathological interpretation?
- Does pathology match imaging and clinical behaviour?
- What result is pending that could change stage or management?